NetworkNewsBreaks

MondayApr 20, 2020 9:42 am

NetworkNewsBreaks – Cannabis Global, Inc. (MCTC) Offers Hemp You Can Feel(TM) Discounts for 420 – Traditional Cannabis Culture Celebration Day

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced special online discount codes for purchases of Hemp You Can Feel(TM) Coffee on April 20 - the traditional cannabis culture celebration day. According to the update, purchases of all products using code ALLUNITED will yield 25% off all products at the www.HempYouCanFeel.com website. "This is a unique product line based on what we believe to be the most bioavailable infusion technologies in the marketplace,” Cannabis Global CEO Arman Tabatabaei stated in the news release. "The organic coffee is super-premium and sourced…

Continue Reading

FridayApr 17, 2020 3:07 pm

NetworkNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Provides Unique, Real-Time, Quality-Assurance Software

Sigma Labs (NASDAQ: SGLB) is leading the commercial 3D-metal-printing industry in providing invaluable quality-control technology throughout the metal-additive manufacturing space. An article discussing the company reads, “Sigma’s proprietary PrintRite3D(TM) is the first additive-manufacturing solution that enables real-time quality control, allowing errors to be detected and corrected in real time, thus saving both money and time. By providing the unique quality-assurance solution that the 3D-metal-printing sector needs, SGLB is set to leverage the latest additive-manufacturing research and processes to ensure the highest-quality, 3D-metal-printing results across a wide variety of sectors, including aerospace, automotive, biomedical and electronics.” To view the full article,…

Continue Reading

FridayApr 17, 2020 2:55 pm

NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Enabling Patients to Access Physicians from Home

Trxade Group’s (NASDAQ: MEDS) wholly owned subsidiary Bonum Health is a virtual telehealth provider that is helping patients to simply and affordably access board-certified physicians and receive medical prescriptions from the comfort of their homes. A recent article discussing the company reads, “On March 4, 2020, Congress approved an $8.3 billion package (http://nnw.fm/8qDeg) in emergency aid to combat the novel coronavirus, which included provisions for Medicare providers to administer telehealth services so that elderly patients, a particularly vulnerable demographic, could receive care at home. The aid package was summarily followed by a coalition of private health insurers, who after a…

Continue Reading

FridayApr 17, 2020 2:00 pm

NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Completes Landmark Shipment of Premium Medical Cannabis Products to Israel

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently completed a landmark shipment containing Supreme Cannabis’ premium medical cannabis product from Canada to Israel (http://nnw.fm/Ob7vr). An article discussing the company reads, “Supreme Cannabis interim president and CEO Colin Moore reported that the transaction, which was made possible through a partnership with Breath of Life International (BOL Pharma), represents a new international revenue opportunity for Supreme Cannabis and ‘builds Truverra’s global medical brand in one of the most sophisticated medical cannabis markets in the world.’ . . .‘With the support of BOL Pharma, we navigated both Canada and Israel’s complex…

Continue Reading

FridayApr 17, 2020 1:50 pm

NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Secures DTC Eligibility

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares are now fully eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”). Champignon’s common shares will continue to trade under the ticker symbol “SHRMF” on the OTC Markets. “We are actively engaged in pursuing new avenues of distribution both in North America and internationally, in order to enhance the ability of larger audiences to participate…

Continue Reading

FridayApr 17, 2020 1:20 pm

NetworkNewsBreaks – Evolus Inc. (NASDAQ: EOLS) Featured in Mizuho Securities Research Report

Evolus Inc. (NASDAQ: EOLS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Evolus announced a business update after the close as the aesthetics-focused company adjusts its cost structure and commercialization strategy in the face of the COVID-19 pandemic. With the majority of US aesthetics practices now closed or only seeing urgent cases, and the economic impact of the pandemic expected to significantly impact discretionary spending for several months, the company is reducing its headcount by >40%, temporarily reducing executive salaries and Board of Director fees, and delaying the European launch of…

Continue Reading

FridayApr 17, 2020 1:19 pm

NetworkNewsBreaks – Xeris Pharmaceuticals Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report

Xeris Pharmaceuticals Inc. (NASDAQ: XERS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We applied a weighted average valuation methodology (DCF+EV/Sales) to derive our $18PT. Our assumptions include: Launch of the glucagon rescue pen in the U.S. market in 4Q19, with peak-sales of $399 mil in 2029. DCF Assumptions: Terminal value of 4.0x 2029 FCF and 13% discount rate to derive a $20 PT. EV/Sales Assumptions: 4.0x multiple of 2025 sales, discounted at 13% to derive a $16 PT. Additional pipeline indications represent upside to our current price target.” To request…

Continue Reading

FridayApr 17, 2020 12:15 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters Securities Purchase Agreement to Raise $3.5 Million

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently entered into a securities purchase agreement with certain accredited investors to purchase shares of common stock (http://nnw.fm/r6SCU). An article discussing the company reads, “The company explained that it has entered into a securities purchase agreement with certain accredited investors to raise $3.5 million through the issuance of up to 1,650,165 shares of common stock (or common stock equivalents) and accompanying warrants to purchase an aggregate of up to 3,300,330 shares of common stock at $2.121 per share of common stock and…

Continue Reading

FridayApr 17, 2020 12:09 pm

NetworkNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) Poised to Profit as Vacation-Rental Industry Forecasted to Skyrocket Over Coming Years

Travel-accommodations insurance provider InsuraGuest Technologies (TSX.V: ISGI) is positioned to benefit from the major growth trajectory in the vacation-rental space after the anticipated recovery of the hospitality sector. A recent article discussing the company reads, “In 2019, the vacation rental industry generated revenues of $57.7 billion (http://nnw.fm/4hrfF), with sales expected to rise to $97.01 billion by 2023 (http://nnw.fm/31oWe). Increasingly, travelers are opting for vacation rentals rather than hotels during their trips, with 71% of travelers with children saying that the ability to cook their own meals was a major draw. However, despite the rising penetration rate of vacation rentals, growth…

Continue Reading

FridayApr 17, 2020 12:04 pm

NetworkNewsBreaks – Aerie Pharmaceuticals Inc. (NASDAQ: AERI) Featured in Mizuho Securities Research Report

Aerie Pharmaceuticals Inc. (NASDAQ: AERI) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We applied a weighted average valuation (DCF and EV/Sales) to derive our $34 PT. Our assumptions include: Rhopressa: U.S. peak-sales of $162 mil in 2025. Rocklatan: U.S. peak-sales of $331 mil in 2025. DCF Assumptions: Terminal value of 5x 2028 FCF and a 13% discount rate to derive a $40 PT. EV/Sales Assumptions: 3.8x multiple of 2028 sales, discounted at 13% to derive a $27 PT. In our bull case scenario, we assume greater than anticipated market share…

Continue Reading